(HR) Healthcare Realty Trust - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4219461047

HR: Medical Buildings, Outpatient Facilities, Healthcare Properties

Healthcare Realty Trust Incorporated (NYSE: HR) stands as a prominent figure in the real estate investment trust (REIT) sector, specializing in medical outpatient facilities strategically positioned near leading hospital campuses. This strategic placement underscores their focus on capturing the demand for convenient, high-quality outpatient care, a sector experiencing growth as healthcare increasingly shifts towards outpatient services.

Their portfolio is both extensive and specialized, comprising over 650 properties that span nearly 40 million square feet across 15 growth markets. This concentration in key areas highlights their commitment to areas with high potential for expansion and demand in healthcare services, positioning them as a leader in their niche.

Growth for Healthcare Realty is achieved through a balanced approach of acquisitions and development, allowing them to expand their footprint while maintaining a focus on quality and strategic fit. Their position as the first and largest REIT in this specialized sector speaks to their expertise and market understanding, crucial for investors seeking stability and growth in the healthcare real estate sector.

From a financial standpoint, Healthcare Realty presents an intriguing profile with a market capitalization of approximately $5.9 billion, offering investors a substantial and established player in the market. Their forward P/E ratio of 10.83 suggests expectations for moderate growth, while a P/S ratio of 4.60 indicates a premium valuation relative to their revenue, reflecting the markets confidence in their business model and growth prospects.

In summary, Healthcare Realty Trust offers a compelling blend of sector expertise, strategic portfolio management, and financial stability, making it a notable consideration for investors and fund managers looking to tap into the growing healthcare real estate market.

Additional Sources for HR Stock

HR Stock Overview

Market Cap in USD 5,831m
Sector Real Estate
Industry REIT - Healthcare Facilities
GiC Sub-Industry Health Care REITs
IPO / Inception 1993-05-26

HR Stock Ratings

Growth 5y 11.3%
Fundamental 9.50%
Dividend 60.8%
Rel. Strength Industry 23.4
Analysts 2.82/5
Fair Price Momentum 18.00 USD
Fair Price DCF 16.64 USD

HR Dividends

Dividend Yield 12m 7.55%
Yield on Cost 5y 8.58%
Annual Growth 5y 0.66%
Payout Consistency 81.8%

HR Growth Ratios

Growth Correlation 3m -14.1%
Growth Correlation 12m 54.5%
Growth Correlation 5y -14.3%
CAGR 5y 2.44%
CAGR/Max DD 5y 0.05
Sharpe Ratio 12m -0.18
Alpha 24.75
Beta 0.54
Volatility 22.57%
Current Volume 2994.2k
Average Volume 20d 2624.1k
What is the price of HR stocks?
As of March 14, 2025, the stock is trading at USD 16.31 with a total of 2,994,248 shares traded.
Over the past week, the price has changed by -1.21%, over one month by +0.31%, over three months by -3.54% and over the past year by +31.13%.
Is Healthcare Realty Trust a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Healthcare Realty Trust is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 9.50 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HR as of March 2025 is 18.00. This means that HR is currently undervalued and has a potential upside of +10.36% (Margin of Safety).
Is HR a buy, sell or hold?
Healthcare Realty Trust has received a consensus analysts rating of 2.82. Therefor, it is recommend to hold HR.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 8
  • Sell: 0
  • Strong Sell: 2
What are the forecast for HR stock price target?
According to ValueRays Forecast Model, HR Healthcare Realty Trust will be worth about 19.4 in March 2026. The stock is currently trading at 16.31. This means that the stock has a potential upside of +19.19%.
Issuer Forecast Upside
Wallstreet Target Price 17.8 9%
Analysts Target Price 18 10.4%
ValueRay Target Price 19.4 19.2%